Related Experiment Video

Updated: May 29, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.2K

Epidemiology of Atrial Fibrillation in Heart Failure

Nikhila Chelikam1, Aashish Katapadi1, Naga Venkata Pothineni1

  • 1Department of Electrophysiology, Kansas City Heart Rhythm Institute, Overland Park, KS 66211, USA.

Cardiac Electrophysiology Clinics
|February 1, 2025
PubMed

Insights

Atrial fibrillation and heart failure are common cardiovascular diseases that worsen each other through complex mechanisms. Understanding their interplay is crucial for improving patient care and outcomes.

Area of Science:

  • Cardiology
  • Pathophysiology
  • Epidemiology

Background:

  • Atrial fibrillation and heart failure are prevalent cardiovascular conditions.
  • These conditions share a complex pathophysiological relationship, impacting morbidity and mortality.
  • The aging population is increasing the burden of these intertwined diseases.

Purpose of the Study:

  • To explore the intricate relationship between atrial fibrillation and heart failure.
  • To understand the pathophysiological mechanisms linking these two conditions.
  • To highlight the importance of epidemiological insights for patient care.

Main Methods:

  • Review of existing literature on atrial fibrillation and heart failure.
  • Analysis of the pathophysiological milieu connecting the two conditions.
  • Discussion of epidemiological trends and their implications.

Main Results:

  • A vicious cycle exists between atrial fibrillation and heart failure, involving neurohormonal changes, inflammation, and myocardial remodeling.
  • Cardiomyopathy can precipitate atrial fibrillation, and atrial fibrillation can lead to heart failure, often making causality difficult to determine.
  • The bidirectional relationship exacerbates disease progression and patient outcomes.

Conclusions:

  • The interplay between atrial fibrillation and heart failure presents a significant challenge in cardiovascular medicine.
  • Further research into the epidemiology and pathophysiology is vital for developing effective therapeutic strategies.
  • Improved understanding is essential for managing these common and impactful cardiovascular conditions.

Keywords:
ArrhythmiaAtrial fibrillationCardiomyopathyEpidemiologyHeart failureIncidenceOutcomesRisk factors

More Related Videos

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

1.6K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.4K

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
884
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
375
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
311
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338
Increased pulse rate01:17

Increased pulse rate

Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
636